Trial
NCT05154630
Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Collaborators
—
Condition
Advanced Cancer
Intervention
TQB2858 injection
Why stopped
The sponsor has decided to terminate this study based on the current clinical research status of dual antibody drugs and full communication with the investigators.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-18